Pharmacy Report Archives - Page 7 of 150 - Becker's Hospital Review

Optum upends drug pricing model | Advocate slashes prior auth delays | GLP-1s tied to breast cancer survival boost | TrumpRx draws 19,000 seeking IVF savings | FDA launches drug repurposing push

Plus: California hospital fined $43K for medication error, prompts immediate jeopardy May 12, 2026 1. 'Gone are the days': Optum Rx to delink drug prices from fees Full story 2. Advocate Health speeds prior authorizations with AI: 5 notes Full…

What would let pharmacists do more: Leaders weigh in | CVS PBM clients gain GLP-1 coverage | Cancer biosimilar reimbursement gap | ASHP's play on workforce | 20 hospital profitability stats

Plus: FDA reconsiders rare lymphoma treatment May 11, 2026 1. What's stopping pharmacists from practicing at the top of their license? Full story 2. Half of CVS Health's PBM clients cover GLP-1s for weight loss Full story 3. Hospital pharmacies…

Oral GLP-1s — What's at stake for hospitals | Trump tariffs: Where things stand | Mounjaro dethrones Keytruda | 10 systems hiring pharmacy leaders | Kaiser claims drug cost edge

Plus: Amazon Pharmacy expands access to Ozempic pill May 7, 2026 1. The strategy questions oral GLP-1s pose for pharmacy leaders Full story 2. Tariffs: Where things stand for healthcare Full story 3. UI Health cut controlled substance waste and…

7 new drug shortages | Trump unveils drug control playbook | Safety groups sound alarm on peptides | CVS shifts formulary | Pharmacists free to swap new insulin biosimilar

Plus: Leapfrog’s spring 2026 grade gap May 6, 2026 1. 7 new drugs in shortage Full story 2. White House outlines drug control strategy: What healthcare leaders should know Full story 3. Procurement inconsistency grows with expansion. Strategies to enforce…

Pharmacy's opportunity overload | 6 pharmacy projects moving the needle | Hospital specialty pharmacies double footprint | GLP-1s eclipse oncology in pipelines | New Alzheimer's drug cleared

Plus: HHS to curb psychiatric overprescribing May 5, 2026 1. How opportunity overload is reshaping pharmacy leadership Full story 2. 6 pharmacy-led projects with meaningful clinical outcomes Full story 3. Inventory gaps, workflow pressure, compliance demands…sound familiar? Discover how pharmacists…

Pharmacy's compliance playbook | Cuban's healthcare strategy | Pharmacist indicted for digital snooping | Court blocks mifepristone mailing | FDA names acting vaccines chief

Plus: GLP-1 use linked to fewer ulcers May 4, 2026 1. The new compliance playbook: How pharmacy leaders are driving change Full story 2. Mark Cuban's healthcare playbook, explained Full story 3. Chief Pharmacy Officers are being asked to lead…

What could break pharmacy by 2035 | GLP-1 compounding under fire | Judge permanently strikes ND 340B law | Drug spend to top $1 trillion | 10 systems hiring pharmacy leaders

Plus: GLP-1s show promise in addiction treatment April 30, 2026 1. What could make or break pharmacy by 2035 Full story 2. FDA seeks to restrict compounding of key GLP-1s Full story 3. Pharmacy procurement breaks at scale. See how…

Cracking the GLP-1 adherence code | Drug shortages climb in 2026 | OxyContin maker hit with $5B+ fine | Pancreatic cancer pill, vaccine show early promise | 10 states with highest, lowest drug use

Plus: FDA approves 1st 2-drug HIV treatment April 29, 2026 1. 3 barriers to GLP-1 adherence — and how systems are overcoming them Full story 2. US drug shortages trending upward in 2026 Full story 3. 80% of health systems…

Trump drug pricing impact to hit in 18 months | AHA fights Lilly's 340B data request: 5 notes | Employers' GLP-1 coverage dilemma | FDA weighs pulling Amgen drug | Utah board moves to halt AI Rx pilot

Plus: 6 big pharma moves April 28, 2026 1. Novartis CEO: Trump drug pricing impact to hit in 18 months Full story 2. AHA urges HHS to block Eli Lilly's 340B data demands: 5 things to know Full story 3.…

How to fix the pharmacy tech pipeline | J&J adds 4 drugs to TrumpRx | Last major drugmaker joins White House pricing push | FDA OKs 1st gene therapy for genetic hearing loss | Cuban inks deal with Eliquis

Plus: Justice Department reclassifies marijuana products April 27, 2026 1. What's broken in the pharmacy tech pipeline — and how leaders would repair it Full story 2. Johnson & Johnson to add 4 drugs to TrumpRx Full story 3. Hear…